Program overview
Context
Indication: Biliary Tract Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Shanghai Zhongshan Hospital
Low Signal
cardonilizumab
cardonilizumab is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 1/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 0/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT05994001
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT05994001 | Low Signal (ACTIVE_NOT_RECRUITING) | long_recruitment_duration_signal | Low Signal | None |